L-deprenyl treatment of on-off phenomena in Parkinson's disease.
D000368:Aged; D001545:Benserazide / Q000627:therapeutic use; D004298:Dopamine / Q000652:urine; D004359:Drug Therapy, Combination; D005260:Female; D006719:Homovanillic Acid / Q000652:urine; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000652:urine; D007980:Levodopa / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000188:drug therapy; D010300:Parkinson Disease / Q000188:drug therapy* / Q000652:urine; D010627:Phenethylamines / Q000627:therapeutic use*; D012642:Selegiline / Q000009:adverse effects / Q000627:therapeutic use*; D014642:Vanilmandelic Acid / Q000652:urine
D010627:Phenethylamines; D012642:Selegiline; D007980:Levodopa; D006897:Hydroxyindoleacetic Acid; D014642:Vanilmandelic Acid; D001545:Benserazide; D004298:Dopamine; D006719:Homovanillic Acid